Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark surveyRuben A. Mesa, John Mascarenhas, Carole B. Miller et al.|Cancer|2016Cited by 91
Burden of Phlebotomy in Patients with Polycythemia Vera in the United States: Baseline Data from the REVEAL StudyRalph V. Boccia, Alison R. Moliterno, Brady L. Stein et al.|Blood|2015Cited by 11
Phlebotomy Frequency and Quality of Life and Productivity in Patients with Polycythemia Vera: Results from the MPN Landmark Survey in the United StatesSalman Fazal, Ruben A. Mesa, Carole B. Miller et al.|Blood|2015Cited by 5
Hydroxyurea Treatment History and Quality of Life in Patients with Polycythemia Vera: Results from the MPN Landmark Survey in the United StatesRuben A. Mesa, James K. Mangan, Shreekant Parasuraman et al.|Blood|2015Cited by 5
Examining the Frequency of Phlebotomy in Patients with Polycythemia Vera (PV) in the United States: An Analysis of Data from the REVEAL StudyRalph V. Boccia, Ruben A. Mesa, Pedro Sanz-Altamira et al.|Blood|2017Cited by 4